New Zealand Medicinal Cannabis Laws: A 2026 Update

New Zealand's medicinal cannabis framework continues to evolve. As of 2026, several important updates have been made to improve patient access and streamline the prescribing process. Here is what you need to know.

Current regulatory framework

Medicinal cannabis remains a prescription-only medicine in New Zealand. The Medicinal Cannabis Agency continues to oversee quality standards, and all products must meet Good Manufacturing Practice (GMP) standards. Products available in New Zealand include oils, capsules, sprays, and dried flower for vaporisation.

Recent changes in 2026

Updates to prescribing guidelines have made it easier for patients to access treatment through telehealth services. The minimum consultation requirements have been clarified, and pathways for ongoing care have been streamlined. These changes reflect the growing recognition of medicinal cannabis as a legitimate treatment option.

Patient access and costs

Consultation fees at Cannalytics remain affordable at $89 for new patient appointments. Follow-up consultations are $45. Some patients may be eligible for ACC funding, and private health insurance may cover consultation costs in some cases. Medication costs vary depending on the product and dosage.

Driving and medicinal cannabis

It is important to note that driving while impaired by any substance, including medicinal cannabis, is illegal. Patients prescribed THC-containing products should discuss driving restrictions with their clinician. For more information, see our FAQ page.